Thyroid antibodies and levothyroxine effects in subclinical hypothyroidism: A pooled analysis of two randomized controlled trials

Antithyroid antibodies increase the likelihood of developing overt hypothyroidism, but their clinical utility remains unclear. No large randomized controlled trial (RCT) has assessed whether older adults with subclinical hypothyroidism (SHypo) caused by autoimmune thyroid disease derive more benefits from levothyroxine treatment (LT4).

[1]  J. Ross,et al.  Levothyroxine Use in the United States, 2008-2018. , 2021, JAMA internal medicine.

[2]  L-Thyroxine Therapy for Older Adults With Subclinical Hypothyroidism and Hypothyroid Symptoms , 2020, Annals of Internal Medicine.

[3]  H. Völzke,et al.  Frequency of thyroid function tests and examinations in participants of a population-based study , 2020, BMC Health Services Research.

[4]  L. Churilov,et al.  Hashimotos' thyroiditis: Epidemiology, pathogenesis, clinic and therapy. , 2019, Best practice & research. Clinical endocrinology & metabolism.

[5]  P. Langhorne,et al.  Association Between Levothyroxine Treatment and Thyroid-Related Symptoms Among Adults Aged 80 Years and Older With Subclinical Hypothyroidism. , 2019, JAMA.

[6]  A. Cappola.  The Thyrotropin Reference Range Should Be Changed in Older Patients. , 2019, JAMA.

[7]  B. Biondi,et al.  Subclinical Hypothyroidism: A Review. , 2019, JAMA.

[8]  N. Rodondi,et al.  Thyroid hormones treatment for subclinical hypothyroidism: a clinical practice guideline , 2019, BMJ.

[9]  P. Taylor,et al.  Trends, Determinants, and Associations of Treated Hypothyroidism in the United Kingdom, 2005-2014. , 2019, Thyroid : official journal of the American Thyroid Association.

[10]  D. Jurkovic,et al.  Levothyroxine in Women with Thyroid Peroxidase Antibodies before Conception , 2019, The New England journal of medicine.

[11]  A. Coomarasamy,et al.  Levothyroxine in Women with Thyroid Peroxidase Antibodies before Conception. Reply. , 2019, The New England journal of medicine.

[12]  D. Bauer,et al.  Association of Thyroid Hormone Therapy With Quality of Life and Thyroid-Related Symptoms in Patients With Subclinical Hypothyroidism: A Systematic Review and Meta-analysis , 2018, JAMA.

[13]  V. Montori,et al.  Levothyroxine overuse: time for an about face? , 2017, The lancet. Diabetes & endocrinology.

[14]  D. Bauer,et al.  Study protocol; Thyroid hormone Replacement for Untreated older adults with Subclinical hypothyroidism - a randomised placebo controlled Trial (TRUST) , 2017, BMC Endocrine Disorders.

[15]  M. Weickert,et al.  Thyroid Hormone Therapy for Older Adults with Subclinical Hypothyroidism. , 2017, The New England journal of medicine.

[16]  B. Lang,et al.  A systematic review of quality of thyroid-specific health-related quality-of-life instruments recommends ThyPRO for patients with benign thyroid diseases. , 2016, Journal of clinical epidemiology.

[17]  M. Malek,et al.  Depressive symptoms in patients with subclinical hypothyroidism – the effect of treatment with levothyroxine: a double-blind randomized clinical trial* , 2015, Endocrine research.

[18]  S. Merrill,et al.  Thyroid autoimmunity as a window to autoimmunity: An explanation for sex differences in the prevalence of thyroid autoimmunity. , 2015, Journal of theoretical biology.

[19]  L. Hegedüs,et al.  Cross-cultural validity of the thyroid-specific quality-of-life patient-reported outcome measure, ThyPRO , 2015, Quality of Life Research.

[20]  N. Rose,et al.  Hashimoto thyroiditis: clinical and diagnostic criteria. , 2014, Autoimmunity reviews.

[21]  B. Biondi.  The normal TSH reference range: what has changed in the last decade? , 2013, The Journal of clinical endocrinology and metabolism.

[22]  P. Ndebele.  The Declaration of Helsinki, 50 years later. , 2013, JAMA.

[23]  G. Brabant,et al.  2013 ETA Guideline: Management of Subclinical Hypothyroidism , 2013, European Thyroid Journal.

[24]  A. Arnold,et al.  Persistent subclinical hypothyroidism and cardiovascular risk in the elderly: the cardiovascular health study. , 2013, The Journal of clinical endocrinology and metabolism.

[25]  Irwin Klein,et al.  Clinical practice guidelines for hypothyroidism in adults: cosponsored by the American Association of Clinical Endocrinologists and the American Thyroid Association. , 2012, Thyroid : official journal of the American Thyroid Association.

[26]  J. Franklyn,et al.  Subclinical hypothyroidism and the risk of coronary heart disease and mortality. , 2010, JAMA.

[27]  P. Leedman,et al.  Thyrotropin and thyroid antibodies as predictors of hypothyroidism: a 13-year, longitudinal study of a community-based cohort using current immunoassay techniques. , 2010, The Journal of clinical endocrinology and metabolism.

[28]  L. Hegedüs,et al.  Validity and reliability of the novel thyroid-specific quality of life questionnaire, ThyPRO. , 2010, European journal of endocrinology.

[29]  D. Sinclair.  Analytical aspects of thyroid antibodies estimation , 2008, Autoimmunity.

[30]  M. Surks,et al.  Age-specific distribution of serum thyrotropin and antithyroid antibodies in the US population: implications for the prevalence of subclinical hypothyroidism. , 2007, The Journal of clinical endocrinology and metabolism.

[31]  J. Weaver,et al.  The beneficial effect of L-thyroxine on cardiovascular risk factors, endothelial function, and quality of life in subclinical hypothyroidism: randomized, crossover trial. , 2007, The Journal of clinical endocrinology and metabolism.

[32]  M. Knuiman,et al.  Investigations of thyroid hormones and antibodies based on a community health survey: the Busselton thyroid study , 2006, Clinical endocrinology.

[33]  B. Wells,et al.  Are thyroid peroxidase antibodies associated with cardiovascular disease risk in patients with subclinical hypothyroidism? , 2005, Clinical endocrinology.

[34]  A. D. de Craen,et al.  Thyroid status, disability and cognitive function, and survival in old age. , 2004, JAMA.

[35]  L. Braverman,et al.  Prospective study of the spontaneous course of subclinical hypothyroidism: prognostic value of thyrotropin, thyroid reserve, and thyroid antibodies. , 2002, The Journal of clinical endocrinology and metabolism.

[36]  C. Doré,et al.  A 6-month randomized trial of thyroxine treatment in women with mild subclinical hypothyroidism. , 2002, The American journal of medicine.

[37]  W Harry Hannon,et al.  Serum TSH, T(4), and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III). , 2002, The Journal of clinical endocrinology and metabolism.

[38]  V. Fatourechi.  Subclinical Hypothyroidism , 2002, Treatments in endocrinology.

[39]  D. Lezotte,et al.  Management practices among primary care physicians and thyroid specialists in the care of hypothyroid patients. , 2001, Thyroid : official journal of the American Thyroid Association.

[40]  G. Canaris,et al.  The Colorado thyroid disease prevalence study. , 2000, Archives of internal medicine.

[41]  D. Vere.  MRC Guidelines for Good Clinical Practice in Clinical Trials , 1999 .

[42]  G. Daniels,et al.  Chronic autoimmune thyroiditis. , 1996, The New England journal of medicine.

[43]  J. French,et al.  The incidence of thyroid disorders in the community: a twenty‐year follow‐up of the Whickham Survey , 1995, Clinical endocrinology.

[44]  A. Kasuya.  EuroQol--a new facility for the measurement of health-related quality of life. , 1990, Health policy.